{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-23-075392","form_type":"8-K","ticker":"CVKD","cik":"0001937993","company_name":"Cadrenal Therapeutics, Inc.","filed_at":"2023-09-08T23:59:59+00:00","discovered_at":"2026-05-14T18:03:36.097384+00:00","generated_at":"2026-06-10T22:21:35.357375+00:00","sec_items":["3.01","9.01"],"event_type":"regulatory","sentiment":"negative","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Cadrenal Therapeutics receives Nasdaq minimum bid price deficiency notice","bullets":["Nasdaq notice on Sept 6, 2023, for bid price below $1.00 for 30 consecutive days.","Company has 180 calendar days until March 4, 2024, to regain compliance.","To comply, closing bid price must be at least $1.00 for 10 consecutive business days.","Company may consider options including reverse stock split to regain compliance.","Delisting not immediate; subject to remaining listing requirements."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-23-075392","json":"https://secwatch.observer/filing/0001213900-23-075392.json","markdown":"https://secwatch.observer/filing/0001213900-23-075392.md","text":"https://secwatch.observer/filing/0001213900-23-075392.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1937993/000121390023075392/0001213900-23-075392-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1937993/000121390023075392/ea184815-8k_cadrenal.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-10T22:21:35.357375+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"5a9a64a32d605ed2e2bce873222c8664b9e4f770","claim":"Cadrenal Therapeutics, Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2)).","evidence_excerpt":"September 6, 2023, Cadrenal Therapeutics, Inc. (the “Company”) received a letter from The Nasdaq Stock Market (“Nasdaq”) stating that the Company was not in compliance with Nasdaq Listing Rule 5550(a)(2) (the “Rule”), requiring listed securities to maintain a minimum bid price of $1.00 per share because the Company’s closing bid price for the last 30 consecutive business days was below $1.00 per share. The notification received has no immediate effect on the Company’s continued listing on the Nasdaq Capital Market, subject to the Company’s compliance with the other continued listing requiremen","evidence_source":"SEC 8-K Item 3.01","evidence_url":"https://www.sec.gov/Archives/edgar/data/1937993/000121390023075392/0001213900-23-075392-index.htm","confidence":0.9,"family_label":"Listing & Compliance Notices","details":[{"label":"Exchange","value":"nasdaq"},{"label":"Notice","value":"deficiency notice"},{"label":"Deficiency","value":"minimum bid price"},{"label":"Rules","value":"5550(a)(2)"}],"fact_type":"exchange_compliance_notice"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}